immunologic deficiency syndromes
Showing 1 - 18 of 18
Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)
Completed
- Immunologic Deficiency Syndromes
- GC5107
-
Centennial, Colorado
- +19 more
Nov 11, 2022
Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)
Recruiting
- Diabetes Mellitus, Type 1
- Immunologic Deficiency Syndromes
- Sequential transplantation
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 4, 2022
Immunity, Vaccine Reaction, Influenza Trial in Barcelona (ABBC1 Immunoessential, Placebo)
Completed
- Immunity
- +5 more
- ABBC1 Immunoessential
- Placebo
-
Barcelona, SpainHospital Mare de Déu de la Mercè - Germanes Hospitalàries
Jul 19, 2022
Novel Mechanisms and Approaches to Treat Neonatal Sepsis
Recruiting
- Complication of Prematurity
- Immunologic Deficiency Syndromes
- Adjuvant
- Blood Collection
-
Gainesville, FloridaUF Health
Nov 4, 2021
Immunologic Deficiency Syndromes Trial in Milano (Strimvelis)
Enrolling by invitation
- Immunologic Deficiency Syndromes
- Strimvelis
-
Milano, Lombardia, ItalyOrchard Investigational Site
Jun 23, 2021
Immunodeficiency: Search for New Genetic Causes for Primary
Recruiting
- Immunologic Deficiency Syndromes
- blood sampling and skin biopsy
- +2 more
-
Zurich, ZH, Switzerland
- +1 more
Apr 12, 2021
Immunologic Deficiency Syndromes Trial in Jerusalem, Milano (Gene Therapy, Busulfan, PEG-ADA)
Completed
- Immunologic Deficiency Syndromes
- Gene Therapy
- +2 more
-
Jerusalem, Israel
- +1 more
Jul 15, 2020
Opportunistic Infections in Immunocompromised and Frail Patients
Unknown status
- Hematologic Disease
- +4 more
-
Strasbourg, FranceUniversity Hospital, Strasbourg, france
Apr 15, 2019
Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome Trial in Minneapolis (Stem
Completed
- Hemophagocytic Lymphohistiocytosis
- +5 more
- Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center University of Minnesota
Dec 3, 2017
Immunologic Deficiency Syndromes Trial in Vienna (Octagam 10%)
Terminated
- Immunologic Deficiency Syndromes
- Octagam 10%
-
Vienna, AustriaContact Barbara Pyringer at Octapharma/ Vienna/ Austria for info
Jun 16, 2017
HIV, AIDS, Lentivirus Infections Trial (Circumcision, Flexible sigmoidoscopy)
Completed
- HIV Infections
- +10 more
- Circumcision
- Flexible sigmoidoscopy
- (no location specified)
Dec 10, 2015
Immunologic Deficiency Syndromes Trial in Canada, United States (Immune Globulin Intravenous (Human) Omr-IgG-am IGIV)
Completed
- Immunologic Deficiency Syndromes
- Immune Globulin Intravenous (Human) Omr-IgG-am IGIV
-
Los Angeles, California
- +9 more
Aug 7, 2014
Immunologic Deficiency Syndromes Trial in Nijmegen (Beta-glucan (Glucan #300®))
Completed
- Immunologic Deficiency Syndromes
- Beta-glucan (Glucan #300®)
-
Nijmegen, NetherlandsRadboud University Nijmegen Medical Centre
Jul 1, 2014
Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome, Common Variable Immunodeficiency Trial in Minneapolis
Terminated
- Immunologic Deficiency Syndromes
- +13 more
- anti-thymocyte globulin
- +8 more
-
Minneapolis, MinnesotaFairview University Medical Center
Oct 14, 2009
Normal Subjects and Patients With Disorders of the Immune System
Completed
- Immunologic Deficiency Syndromes
- Neoplasms
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 4, 2008
HIV, Immunologic Deficiency Syndromes, Lymphoproliferative Disorders Trial run by the NCI (all-trans-retinoic acid with
Completed
- HIV Infections
- +2 more
- all-trans-retinoic acid with IFN-alpha2a
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
AIDS, Aspergillosis, HIV Trial run by the NIAID (Voriconazole, Amphotericin B)
Completed
- Acquired Immunodeficiency Syndrome
- +4 more
- Voriconazole
- Amphotericin B
-
Bethesda, MarylandNational Institute of Allergy and Infectious Diseases (NIAID)
Mar 3, 2008
Herpes Zoster, Immunologic Deficiency Syndromes Trial in Houston (Valacyclovir)
Completed
- Herpes Zoster
- Immunologic Deficiency Syndromes
-
Houston, TexasCenter for Clinical Studies
May 22, 2007